Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
This study has been completed.
University of Cincinnati
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Mohamed Tarek Shata, University of Cincinnati
First received: January 20, 2012
Last updated: May 26, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||December 2014|
|Primary Completion Date:||July 2014 (Final data collection date for primary outcome measure)|